LCA-Vision Stock Price, News & Analysis (NASDAQ:LCAV)

Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About LCA-Vision (NASDAQ:LCAV)

LCA-Vision Inc. is a provider of fixed-site laser vision correction services at its LasikPlus vision centers. The Company's vision centers provide the staff, facilities, equipment and support services for performing laser vision correction that employ advanced laser technologies to help correct nearsightedness, farsightedness and astigmatism. The Company's vision centers are supported by independent, ophthalmologists and credentialed optometrists, as well as other healthcare professionals. The ophthalmologists perform the laser vision correction procedures in the Company's vision centers, and ophthalmologists or optometrists conduct pre-procedure evaluations and post-operative follow-up care in-center. Most of the Company's patients receive a procedure called laser-assisted in situ keratomileusis (LASIK). As of December 31, 2011, it had performed over 1.2 million laser vision correction procedures in its vision centers in the United States and Canada.

Receive LCAV News and Ratings via Email

Sign-up to receive the latest news and ratings for LCAV and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorHealthcare
SymbolNASDAQ:LCAV
CUSIPN/A
Phone+1-513-7929292

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A

LCA-Vision (NASDAQ:LCAV) Frequently Asked Questions

What is LCA-Vision's stock symbol?

LCA-Vision trades on the NASDAQ under the ticker symbol "LCAV."

How were LCA-Vision's earnings last quarter?

LCA-Vision Inc. (NASDAQ:LCAV) released its quarterly earnings results on Wednesday, April, 30th. The healthcare company reported ($0.01) EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.23 by $0.24. The healthcare company had revenue of $25.53 million for the quarter, compared to analysts' expectations of $32.04 million. View LCA-Vision's Earnings History.

Who are some of LCA-Vision's key competitors?

How do I buy LCA-Vision stock?

Shares of LCA-Vision can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact LCA-Vision?

LCA-Vision's mailing address is 7840 Montgomery Rd, CINCINNATI, OH 45236-4301, United States. The healthcare company can be reached via phone at +1-513-7929292.


MarketBeat Community Rating for LCA-Vision (LCAV)

Community Ranking:  3.4 out of 5 (star star star)
Outperform Votes:  34 (Vote Outperform)
Underperform Votes:  16 (Vote Underperform)
Total Votes:  50
MarketBeat's community ratings are surveys of what our community members think about LCA-Vision and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

LCA-Vision (NASDAQ:LCAV) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

LCA-Vision (NASDAQ:LCAV) Earnings History and Estimates Chart

Earnings by Quarter for LCA-Vision (NASDAQ:LCAV)

LCA-Vision (NASDAQ LCAV) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/30/2014Q1 2014$0.23($0.01)$32.04 million$25.53 millionViewN/AView Earnings Details
2/18/2014Q4($0.08)($0.08)$20.55 million$20.60 millionViewListenView Earnings Details
7/30/2013Q2 2013($0.11)$0.02$23.00 million$22.60 millionViewListenView Earnings Details
7/31/2012($0.14)($0.17)ViewN/AView Earnings Details
4/24/2012$0.18$0.20ViewN/AView Earnings Details
2/14/2012($0.21)($0.09)ViewN/AView Earnings Details
10/25/2011($0.22)($0.20)ViewN/AView Earnings Details
7/26/2011($0.14)($0.15)ViewN/AView Earnings Details
4/26/2011($0.03)$0.11ViewN/AView Earnings Details
2/16/2011($0.38)($0.39)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

LCA-Vision (NASDAQ:LCAV) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for LCA-Vision (NASDAQ:LCAV)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

LCA-Vision (NASDAQ LCAV) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for LCA-Vision (NASDAQ:LCAV)

LCA-Vision (NASDAQ LCAV) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/14/2013Michael J CelebrezzeCEOBuy3,450$2.90$10,005.00View SEC Filing  
2/28/2013Amy F KappenCFOBuy1,023$3.00$3,069.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

LCA-Vision (NASDAQ LCAV) News Headlines

Source:
DateHeadline
John Gutfreund Dies at 86; Transformed Salomon Into a Trading GiantJohn Gutfreund Dies at 86; Transformed Salomon Into a Trading Giant
www.thestreet.com - March 10 at 10:53 AM
Lca-Vision Inc. Company ProfileLca-Vision Inc. Company Profile
biz.yahoo.com - February 28 at 10:14 AM

SEC Filings

LCA-Vision (NASDAQ:LCAV) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

LCA-Vision (NASDAQ:LCAV) Income Statement, Balance Sheet and Cash Flow Statement

Chart

LCA-Vision (NASDAQ LCAV) Stock Chart for Tuesday, December, 12, 2017

Loading chart…

This page was last updated on 12/12/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.